Sonnet BioTherapeutics Holdings, Inc.
SONN
$1.36
-$0.01-0.73%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 34.78% | 60.51% | 64.65% | 68.23% | 50.25% |
| Total Depreciation and Amortization | 10.21% | 9.63% | 9.16% | 0.13% | -10.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 56.06% | 15.98% | -9.12% | -65.57% | -74.74% |
| Change in Net Operating Assets | 106.44% | 40.01% | -128.70% | -930.31% | -353.07% |
| Cash from Operations | 54.50% | 59.67% | 56.59% | 46.93% | 27.65% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 97.29% | 97.29% | 13.99% | 76.84% | 35.77% |
| Cash from Investing | 97.29% | 97.29% | 13.99% | 76.84% | 35.77% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -- | -- |
| Issuance of Common Stock | -46.93% | -67.17% | -69.82% | -72.87% | 216.97% |
| Repurchase of Common Stock | -23.16% | -23.16% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -49.32% | -69.08% | -73.19% | -75.55% | 136.46% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 39.31% | -172.91% | -292.98% | -238.66% | 107.46% |